Novo Nordisk

+$0.37 (+0.40%) As of 7:20 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals.

CEO

Lars Fruergaard Jørgensen

Employees

45,323

Headquarters

Bagsværd, Capital Region

Founded

1925

NVO Key Statistics

Market Cap

192.95B

Price-Earnings Ratio

32.00

Dividend Yield

1.11

Average Volume

1.15M

High Today

$92.99

Low Today

$91.67

Open Price

$92.19

Volume

578.13K

52 Week High

$92.99

52 Week Low

$63.22

NVO News

Los Angeles TimesJul 29

A diabetes drug’s new weight management formula comes with a big price

Ads for the latest drugs to treat Type 2 diabetes sometimes include an unusual warning: They might cause weight loss. That side effect is one that many people —

Analyst Ratings

50%

of 28 ratings

Buy

50%

Hold

32.1%

Sell

17.9%

NVO Earnings

$0.00

$0.29

$0.59

$0.88

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Aug 13, Pre-Market